Health Care/Hospital

Burjeel Holdings Oncology Conference Marks 10 Years, Focusing on Equitable Solutions for Cancer Care

Experts stress collaboration and innovation are key to progress WASHINGTON, Dec. 19, 2023 /PRNewswire/ -- The 10th anniversary of the Burjeel Holdings Oncology Conference, held in partnership with Foreign Policy, brought together leading global experts to tackle the complex challenges of cancer ...

2023-12-19 20:20 1816

LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches

ANDERNACH, Germany, Dec. 19, 2023 /PRNewswire/ -- LTS, a leading pharmaceutical technology company, announced today that it has received a grant from the Bill & Melinda Gates Foundation. The purpose of the grant is to support the development of microneedle array patches (MAP) for self-administrat...

2023-12-19 20:00 1249

New Drug Application of Mabwell's 8MW0511 for Injection Accepted by NMPA

SHANGHAI, Dec. 19, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that the new drug application of its recombinant (yeast-secreted) human serum albumin-human granulocyte colony-stimulating factor (I) fusion protein for injec...

2023-12-19 20:00 1198

Cutting-Edge Gut Microbiome Research: NOSTER's latest solutions for comprehensive gut bacteria-based metabolite and microbiota analysis

KYOTO, Japan, Dec. 19, 2023 /PRNewswire/ -- Japan's Noster Inc., a premier provider of gut microbiome analysis services, is proud to unveil groundbreaking updates in its research on cutting-edge gut bacteria-based metabolite and gut microbiota analysis services. These advancements have far-reachi...

2023-12-19 19:22 1334

Paving the Way Towards a More Sustainable Future - Fullerton Health Accelerates Regional Growth with Sustainability Framework

SINGAPORE, Dec. 19, 2023 /PRNewswire/ -- Fullerton Health Group (FHG) continues to make important strides toward integrating its sustainability goals within its operations and ecosystem. The release of its FY2022 Sustainability Report underscores the Group's commitments and progress in achieving ...

2023-12-19 16:13 1444

Tianjin's Youthful Energy Sparks Citywide Revival

TIANJIN, China, Dec. 19, 2023 /PRNewswire/ -- A report from China Daily: Tianjin, a city in North China, is undergoing a dynamic transformation driven by its vibrant young people. China Daily Potside Chats hosts, Nathan and Stephanie, recently explored the city's cutting-edge developments led by ...

2023-12-19 15:44 1370

Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment Paradigm

MedTech Insights report series analyzes the impact of recent breakthroughs in pulsed-field ablation, signaling its promising future in the electrophysiology mapping and ablation device market LONDON, Dec. 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people an...

2023-12-19 15:00 1250

Roche navify digital solutions get excellent ratings from healthcare professionals in KLAS Research reports

* Healthcare professionals greatly value navify Tumor Board for improving tumour board meeting experiences, offering a holistic view of data, facilitating multidisciplinary team collaboration and optimising care decisions * navify POC Operations attains excellent ratings from health professio...

2023-12-19 14:00 3790

Innovent and AnHeart Therapeutics Announce the National Medical Products Administration of China Has Granted Taletrectinib (ROS1 Inhibitor) Priority Review Designation

ROCKVILLE, Md. and SUZHOU, China, Dec. 19, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology an...

2023-12-19 08:00 6137

Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix™) for Imaging of Kidney Cancer

MELBOURNE, Australia and INDIANAPOLIS, Dec. 19, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) tothe United States (U.S.) Food and Drug Administration (FDA) for its investigational pos...

2023-12-19 05:44 1431

EQT Private Equity to acquire Zeus, a global leader in advanced polymer components used in life-saving medical procedures

* EQT Private Equity to acquire Zeus, a leading supplier of custom polymer components to the world's most innovative medical device and industrial companies * Transaction highlights EQT's commitment to partnering with leading, purpose-driven companies that deliver inherently critical service...

2023-12-18 23:30 1359

RNAimmune Receives Investigational New Drug Application Clearance from U.S. FDA for mRNA-Based Respiratory Syncytial Virus Vaccine RV-1770

GERMANTOWN, Md and GUANGZHOU, China, Dec. 18, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announc...

2023-12-18 22:04 1833

Biorithm Secures $3.5 Million in Series A Funding to Advance Maternal Care Worldwide

New funds to fortify US market entry and growth strategy, as well as advance breakthrough research CAMBRIDGE, Mass., Dec. 18, 2023 /PRNewswire/ -- Biorithm, a global women's health medtech, has closed$3.5 million in Series A funding, co-led by Adaptive Capital Partners and SEEDS Capital. With a ...

2023-12-18 22:00 1250

GomSpace enters into Joint Venture with French company Ellipse Partners SAS

STOCKHOLM, Dec. 18, 2023 /PRNewswire/ -- GomSpace and Ellipse Projects SAS from France enters a Joint Venture with the purpose of acquiring a contract for monitoring of marine and fishing resources aroundIndonesia. A Tender of a potential value of 150 MEUR (1.6 BSEK), has been awarded to the Join...

2023-12-18 21:48 1250

RemeGen Announces Continued Inclusion of Telitacicept and Disitamab Vedotin in China National Reimbursement Drug List, Ensuring Continuous Accessibility of Innovative Drugs for More Patients

YANTAI, China, Dec. 18, 2023 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, has recently confirmed that under the 2023 simple renewal mechanism of China National Healthcare Security Adminis...

2023-12-18 20:56 1316

Biocon Biologics Concludes Integration of Acquired Biosimilars Business in ~120 countries

10+ Emerging Markets, Japan & ANZ Transition in Final Phase KUALA LUMPUR, Malaysia, Dec. 18, 2023 /PRNewswire/ -- Biocon Biologics, a unique, fully integrated, global biosimilars company with a rich portfolio of insulins and monoclonal antibodies, has successfully concluded the integration of th...

2023-12-18 20:44 1535

Neuren Phase 2 trial shows significant improvements in Phelan-McDermid syndrome

Highlights:  * Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures   * Improvements were consistently seen across clinically important aspects of Phelan-McDermid syndrome, including communication, behaviour, cognition/learning and socialis...

2023-12-18 19:00 1075

NUS researchers develop an innovative and flexible method to study immune cell capabilities

This simple and efficient method can directly identify and sort immune cells involved in cell-mediated cytotoxicity SINGAPORE, Dec. 17, 2023 /PRNewswire/ -- Our body's immune system is a complex network of organs, cells, and proteins that work in synchrony to protect our bodies against infection...

2023-12-18 14:47 1272

IDS Medical Systems Philippines, Inc.'s Corporate Excellence has been Acknowledged at the Asia Pacific Enterprise Awards 2023 Regional Edition

SINGAPORE, Dec. 18, 2023 /PRNewswire/ -- In a dazzling celebration of regional excellence, the Asia Pacific Enterprise Awards (APEA) 2023 Regional Edition took center stage to honor outstanding businesses and visionary leaders who have played a pivotal role in propelling their enterprises to new ...

2023-12-18 10:08 1444

Dr. Steve Mark Gan and His Company GAOC Group of Companies Claim Victory at the Asia Pacific Enterprise Awards 2023 Regional Edition

SINGAPORE, Dec. 18, 2023 /PRNewswire/ -- The Asia Pacific Enterprise Awards (APEA) 2023 Regional Edition served as a magnificent tribute to exceptional businesses and forward-thinking leaders in the region. Following the Asia Economic Forum (AEF) 2023 inSingapore, which convened over 300 delegate...

2023-12-18 10:06 1468
1 ... 52535455565758 ... 808